VAI Finding Could Lead To New Drugs For Anxiety, Depression - How CRF Precisely Binds To Its Receptor (Medical News Today)
Researchers in the Laboratory of Structural Sciences at Van Andel Institute (VAI) have determined how the hormone corticotrophin releasing factor (CRF) precisely binds to its receptor. This detailed structural information can help drug developers design new drugs for anxiety, depression, and related disorders.